Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.11
+0.07 (0.33%)
Mar 9, 2026, 3:23 PM EDT - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $2.39 billion as of March 9, 2026. Its market cap has increased by 188.88% in one year.
Market Cap
2.39B
Enterprise Value
1.69B
1-Year Change
188.88%
Ranking
Category
Stock Price
$21.11
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.39B, an increase of 2,044.02%. That is a compound annual growth rate of 75.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apellis Pharmaceuticals | 2.57B |
| Telix Pharmaceuticals | 2.56B |
| Travere Therapeutics | 2.51B |
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |
| Tango Therapeutics | 2.42B |
| Disc Medicine | 2.33B |
| Adaptive Biotechnologies | 2.29B |